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Abstract
Background: Little information is available on the circadian sequela of an immune challenge in the
brain of aged rats. To assess them, we studied 24-hour rhythms in hypothalamic and striatal
norepinephrine (NE) content, hypothalamic and striatal dopamine (DA) turnover and hypophysial
NE and DA content, in young (2 months) and aged (18–20 months) rats killed at 6 different time
intervals, on day 18th after Freund's adjuvant or adjuvant's vehicle administration.
Results: Aging decreased anterior and medial hypothalamic NE content, medial and posterior
hypothalamic DA turnover, and striatal NE concentration and DA turnover. Aging also decreased
NE and DA content in pituitary neurointermediate lobe and augmented DA content in the anterior
pituitary lobe. Immunization by Freund's adjuvant injection caused: (i) reduction of DA turnover in
anterior hypothalamus and corpus striatum; (ii) acrophase delay of medial hypothalamic DA
turnover in old rats, and of striatal NE content in young rats; (iii) abolition of 24-h rhythm in NE
and DA content of neurointermediate pituitary lobe, and in DA content of anterior lobe, of old
rats.
Conclusions: The decline in catecholamine neurotransmission with aging could contribute to the
decrease of gonadotropin and increase of prolactin release reported in similar groups of rats. Some
circadian responses to immunization, e.g. suppression of 24-h rhythms of neurointermediate lobe
NE and DA and of anterior lobe DA were seen only in aged rats.
Background
In 1974, Pittendrigh and Daan first described the chang-
es caused by aging in the circadian timing system of ro-
dents [1]. Since then, a bulk of information has
accumulated indicating that reduced amplitude, shorter
free-running periods and desynchronization of circadian
rhythms are associated with advanced age in rodents as
well as in humans (for references see [2]). Both the effi-
cacy of input and output pathways from the central nerv-
ous system circadian pacemaker, located in the
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hypothalamic suprachiasmatic nuclei, and the function-
ing of the central pacemaker itself, change with advanc-
ing age. In addition, some of the decline in overt
circadian rhythmicity may be due to deteriorating func-
tion of the body's aging effector systems [2].
An aspect of circadian organization in aged subjects less
known is the modification in amplitude or phase of circa-
dian rhythms during the different phases of the response
to an immune challenge. Since aging is associated with
declines in multiple areas of immune function [3], it
seems feasible that differences in the circadian response
to an immune challenge with age occur.
Adjuvant arthritis is an experimental model for rheuma-
toid arthritis, induced by the intradermal injection of
heat-killed Mycobacterium tuberculosis in incomplete
Freund's adjuvant to rats [4]. In the classical adjuvant-
induced arthritis model, polyarthritis is accompanied by
a widespread systemic disease. In this experimental
model we previously reported the effect of aging on cir-
cadian organization of plasma prolactin, growth hor-
mone (GH), thyrotropin (TSH), insulin, follicle-
stimulating hormone (FSH), luteinizing hormone (LH)
and testosterone, studied during the acute phase of in-
flammatory disease of the joints (18 days after Freund's
adjuvant injection) in rats [5]. As a continuation of those
studies we now report, in comparable groups of animals,
the changes in 24-hour organization of hypothalamic
and striatal norepinephrine (NE) content and dopamine
(DA) turnover and hypophysial NE and DA content. The
results support the view that 24-h rhythms and levels of
hypothalamic, striatal and hypophysial catecholamines
are age-dependent, as are some of the responses to Fre-
und's adjuvant administration.
Results
Figure 1 shows the 24-h changes in hypothalamic NE
content in young and old rats injected with Freund's ad-
juvant or its vehicle 18 days earlier. Rhythm parameters
as analyzed by Cosinor are summarized in Table 1. In the
three hypothalamic regions examined significant 24-h
changes of NE content occurred, as shown by individual
oneway analysis of variance (ANOVA) (Fig. 1). In the ex-
perimental groups in which data fitted a cosine function,
acrophases coincided with the second half of activity
span or the first half of rest span (04:06 – 13:08 h. Table
1). A factorial ANOVA taking age as a main factor re-
vealed a significantly lower NE content in anterior and
medial hypothalamus of aged rats (F1,126= 8.76, p <
0.004, and F1,122 = 4.83, p < 0.03, respectively). In Cosi-
nor, mesor values of NE content in anterior hypothala-
mus and amplitude values in posterior hypothalamus of
old rats were significantly lower than their respective
younger counterparts (Table 1).
Figure 2 depicts the 24-h changes in hypothalamic DA
turnover. Individual one-way ANOVA's indicated signif-
icant time-of-day changes in the anterior hypothalamus
of all experimental groups, in the medial hypothalamus
of young rats treated with Freund's adjuvant and of old
rats treated with adjuvant's vehicle, and in the posterior
hypothalamus of young and old rats treated with adju-
vant's vehicle. Acrophases occurred during the second
half of activity span or first half of rest span (04:00 –
13:47 h), except for the medial hypothalamus of Freund's
adjuvant-treated young rats whose acrophases were at
the beginning of the activity span (20:17 h. Table 1). A
factorial ANOVA taking age as a main factor indicated
that medial and posterior hypothalamic DA turnover was
significantly lower in old rats (F1,124 = 5.29, p < 0.01 and
F1,121 = 6.41, p < 0.001, respectively). Mean values (pg/
mg) of 3,4-dihydroxyphenylacetic acid (DOPAC) and DA
in young rats were: 38 ± 2.7 and 147 ± 11 (anterior hy-
pothalamus); 83 ± 5.5 and 72 ± 4 (medial hypothala-
mus); 10 ± 1 and 27 ± 2.3 (posterior hypothalamus).
Mean values (pg/mg) of DOPAC and DA in old rats were:
31 ± 2 and 122 ± 9 (anterior hypothalamus); 65 ± 6.6 and
68 ± 5 (medial hypothalamus); 7 ± 1 and 26 ± 1.7 (poste-
rior hypothalamus). In every hypothalamic region of old
rats DOPAC concentration was lower than that of young
rats (p < 0.05, Student's t test). When immunization was
taken as a main factor in factorial ANOVA, a significant
reduction in DA turnover was found in the anterior hy-
pothalamus of Freund's adjuvant-treated rats (F1,123 =
3.99, p < 0.04). Mean values (pg/mg) of DOPAC and DA
in the anterior hypothalamus of adjuvant's vehicle- and
Freund's adjuvant-treated rats were: 37 ± 2.3 and 125 ±
13, and 33 ± 1.9 and 130 ± 12, respectively.
Figure 3 depicts striatal NE content and DA turnover.
Striatal NE content varied significantly on a 24-h basis.
Acrophases coincided with the second half of activity
span or the first half of rest span (06:29 – 12:16 h), ex-
cept for young rats treated with Freund's adjuvant in
which acrophase occurred late in the rest span (17:15 h)
(Table 2). Differences in acrophases between immunized
and non-immunized young rats were significant (Table
2). Analyzed as a main factor in a factorial ANOVA, old
rats had lower striatal NE concentrations (F1,121 = 8.76,
p < 0.003). In every case, old rats showed smaller mesor
values of striatal NE content than their younger counter-
parts (Table 2). Amplitude decreased significantly in old
rats injected with Freund's adjuvant (Table 2).
Time-of-day changes in striatal DA turnover were not
significant as indicated by individual one-way ANOVA's
(Fig. 3). In a factorial ANOVA, the effects of both main
factors "age" and "immunization" were significant, aging
and Freund's adjuvant decreasing striatal DA turnover
(F1,122 = 5.97, p < 0.01 and F1,123 = 13.4, p < 0.00001, re-BMC Physiology 2001, 1:14 http://www.biomedcentral.com/1472-6793/1/14
spectively). Mean values (pg/mg) of striatal DOPAC and
DA in young and old rats were: 437 ± 52 and 3123 ± 225,
and 189 ± 21 and 2631 ± 202, respectively. Differences in
striatal DOPAC concentration between young and old
rats were significant (p < 0.01, Student's t test). Mean
values (pg/mg) of striatal DOPAC and DA in adjuvant's
vehicle-and Freund's adjuvant-treated rats were: 411 ±
54 and 2417 ± 256, and 215 ± 25 and 2152 ± 234, respec-
tively. The decrease in striatal DOPAC concentration af-
ter Freund's adjuvant administration was significant (p
< 0.01, Student's t test).
Hypophysial NE and DA levels are depicted in Fig. 4. NE
levels of the neurointermediate lobe showed significant
24-h variations in all groups except for old rats receiving
Freund's adjuvant. Acrophases were at 02:31 – 03:34 h
(Table 3). In a factorial ANOVA in which age was ana-
lyzed as a main factor, a significant depression of NE
content was detected in aged rats (F1,123 = 10.1, p <
0.0001). Mesor values were significantly lower in old
rats. Amplitude in old rats receiving adjuvant's vehicle
was significantly lower than that of their respective
young counterparts (Table 3).
Significant 24-h changes in DA content of the neuroin-
termediate lobe occurred in the 4 experimental groups,
except for old rats receiving Freund's adjuvant (Fig. 4);
acrophases were at 02:47 – 04:23 h (Table 3). A factorial
ANOVA indicated a depressive effect of aging on neu-
rointermediate lobe DA content (F1,126 = 28.4, p <
0.00001). In Cosinor, mesor and amplitude values in old
rats receiving adjuvant's vehicle were significantly lower
than those of their respective young counterparts (Table
3).
Figure 1
Twenty-four h changes of hypothalamic NE content in young and old rats injected with Freund's adjuvant or its vehicle 18 days
earlier. Groups of 5–7 rats were killed by decapitation at six different time intervals throughout a 24-h cycle. Shown are the
means + SEM. The groups in which significant differences among time intervals were detected by a one-way ANOVA are indi-
cated by their F values in the Figure. For further statistical analysis, see text.BMC Physiology 2001, 1:14 http://www.biomedcentral.com/1472-6793/1/14
Figure 4, lower panel, depicts DA levels in the anterior
hypophysis. Significant 24-h changes were observed in
all groups except for old rats administered with Freund's
adjuvant. Only changes in young animals injected with
adjuvant's vehicle fit a cosine function, with acrophase at
10:31 h. In a factorial ANOVA, aging augmented anterior
hypophysial DA levels (F1,122 = 37.8, p < 0.00001).
Discussion
The present study, performed in rats sacrificed at 6 dif-
ferent time intervals during a 24-h cycle, documented
the following effects of aging on hypothalamic, striatal
and hypophysial catecholamines: (i) lower NE content in
anterior and medial hypothalamus; (ii) lower DA turno-
ver in medial and posterior hypothalamus; (iii) lower
striatal NE concentration and DA turnover; (iv) lower
NE and DA content of the neurointermediate pituitary
lobe; (v) augmented anterior hypophysial DA content. In
addition, the identified effects of Freund's adjuvant ad-
ministration were: (i) reduction of DA turnover in the
anterior hypothalamus; (ii) acrophase delay of DA turn-
over in medial hypothalamus of old rats; (iii) acrophase
delay of striatal NE content of young rats; (iv) decreased
striatal DA turnover; (v) abolished 24-h variations of
neurointermediate lobe NE and DA content, and of ante-
rior lobe DA content, in old rats.
Table 1: Cosinor analysis on 24-h changes in hypothalamic NE content and DA turnover in young and old rats injected with Freund's 
adjuvant or its vehicle 18 days earlier.
Mesor Amplitude Acrophase (h, min) Percent of rhythm
NE CONTENT
Anterior hypothalamus
Young, Freund's adjuvant 1030 ± 99 428 ± 34 12:36 ± 02:01 65 ± 12
Young, adjuvant's vehicle 1073 ± 113 444 ± 56 08:09 ± 02:35 51 ± 6.5
Old, Freund's adjuvant 803 ± 77* 499 ± 66 13:08 ± 02:13 48 ± 6.6
Old, adjuvant's vehicle 731 ± 98* -- -
Medial hypothalamus
Young, Freund's adjuvant 661 ± 76 - - -
Young, adjuvant's vehicle 762 ± 55 225 ± 35 08:40 ± 02:08 44 ± 5.9
Old, Freund's adjuvant 618 ± 64 - - -
Old, adjuvant's vehicle 557 ± 43 285 ± 43 04:06 ± 02:34 70 ± 6.9
Posterior hypothalamus
Young, Freund's adjuvant 142 ± 32 55 ± 9 06:24 ± 02:44 49 ± 9.7
Young, adjuvant's vehicle 143 ± 13 62 ± 11 08:50 ± 02:03 81 ± 10.1
Old, Freund's adjuvant 143 ± 33 36 ± 4* 10:35 ± 01:33 53 ± 7.8
Old, adjuvant's vehicle 152 ± 27 38 ± 6* 11:26 ± 02:22 70 ± 9.2
DA TURNOVER
Anterior hypothalamus
Young, Freund's adjuvant 0.26 ± 0.01 - - -
Young, adjuvant's vehicle 0.27 ± 0.03 0.08 ± 0.01 06:51 ± 01:02 64 ± 3.4
Old, Freund's adjuvant 0.24 ± 0.02 0.05 ± 0.02 13:47 ± 01:47 59 ± 6.4
Old, adjuvant's vehicle 0.30 ± 0.01 0.05 ± 0.01 09:28 ± 02:21 53 ± 7.7
Medial hypothalamus
Young, Freund's adjuvant 1.04 ± 0.01 0.22 ± 0.03 20:17 ± 02:33 62 ± 7.7
Young, adjuvant's vehicle 1.16 ± 0.02 n.s. n.s. n.s.
Old, Freund's adjuvant 0.96 ± 0.02 n.s. n.s. n.s.
Old, adjuvant's vehicle 0.96 ± 0.03 - - -
Posterior hypothalamus
Young, Freund's adjuvant 0.34 ± 0.01 n.s. n.s. n.s.
Young, adjuvant's vehicle 0.38 ± 0.02 0.05 ± 0.02 09:20 ± 02:36 29 ± 4.4
Old, Freund's adjuvant 0.32 ± 0.02 n.s. n.s. n.s.
Old, adjuvant's vehicle 0.30 ± 0.01 0.07 ± 0.01 04:00 ± 01:35 39 ± 4.9
Shown are the means ± S.E.M. (n = 5–7/group). Mesor and amplitude values are expressed as pg/mg (NE content) or as DOPAC/DA ratios. Percent 
of rhythm defines the part of variation that could be explained by a cosine function in Cosinor. Asterisks designate significant differences (p < 0.05) 
as compared to the respective young counterparts in a one-tailed Student's t test. n.s.: not significant daily changes in a oneway ANOVA; (-): not 
significant changes in CosinorBMC Physiology 2001, 1:14 http://www.biomedcentral.com/1472-6793/1/14
Most previous studies on the effect of aging on brain and
peripheral catecholamines in rats have been obtained as
single time points in a 24-h cycle. Decreases in NE con-
tent in limbic areas, spinal cord, medulla oblongata and
pons, and less consistently, in the hypothalamus and cor-
pus striatum of old rats were identified [6–12]. In aging
male rats, levels of hypothalamic NE either decreased
[6,13–16] or remained unchanged [9,17,18].
Our present results indicate that aged rats had lower NE
content in the anterior and medial hypothalamus. In ad-
dition, hypothalamic NE levels showed significant 24-h
changes with acrophases at the second half of activity
span or first half of rest span. In the posterior hypothala-
mus of old rats, amplitude of rhythm was significantly
lower than in their respective younger counterparts.
Since noradrenergic neurons stimulate LH releasing
hormone release [19], the decline in noradrenergic stim-
ulation with aging could contribute to the age-related de-
crease of FSH and LH described previously in similar
groups of rats [5]. It should be noted that a strong posi-
tive correlation did exist between the rate constant of NE
loss measured in rats and the magnitude of the age-relat-
ed depletion in NE concentrations within specific brain
regions [20].
The present results also support the existence of a lower
DA turnover in medial and posterior hypothalamus of
aged rats. This was the consequence of a decrease of both
DA and DOPAC concentration, being most marked in the
case of the latter. DA released by tuberoinfundibular
dopaminergic neurons in the hypothalamic periventricu-
lar and arcuate nuclei tonically inhibits pituitary prolac-
tin secretion. In turn, prolactin stimulates DA secretion
Figure 2
Twenty-four h changes of hypothalamic DA turnover in young and old rats injected with Freund's adjuvant or its vehicle 18
days earlier. Groups of 5–7 rats were killed by decapitation at six different time intervals throughout a 24-h cycle. Shown are
the means + SEM. The groups in which significant differences among time intervals were detected by a one-way ANOVA are
indicated by their F values in the Figure (n.s.: not significant F). For further statistical analysis, see text.BMC Physiology 2001, 1:14 http://www.biomedcentral.com/1472-6793/1/14
from dopaminergic neurons, forming a feedback loop
[21,22]. This autoregulatory feedback control of prolac-
tin is altered in the aged rat, as evidenced by increased
circulating concentrations of prolactin and decreased ac-
tivity of these neurons [22,23]. In addition, tuberoin-
fundibular DA neurons of old rats failed to respond to
exogenous prolactin administration [24].
Prolactin increases occur with aging in male rats of most
strains, including Wistar [25] and Long-Evans [26] rats,
but not in all, e.g. Sprague-Dawley [27] rats. Most studies
have reported a decrease in DA content in the hypothala-
mus and median eminence of aging male rats, including
Wistar [14,15], Long-Evans [28], Sprague-Dawley [9]
and F344 [16] rats. In the present study, medial hypoth-
alamic, as well as median eminence DA levels (data not
shown), decreased with age. Since the decreases in
DOPAC levels exceeded those of DA, DA turnover rate
also decreased. Our results agree with measurements of
hypothalamic DA turnover in aged Wistar [14] and Long-
Evans [28] rats at single time-points in a 24-h cycle.
In vivo, secretion of DA into hypophysial portal blood
has been reported to decrease [29] or to increase with ag-
ing [30]. Long-term (12 months) testosterone replace-
ment in 24-month-old male Wistar rats increased DA
release in the medial preoptic area nearly to levels ob-
served in 3-month-old rats [31]. These findings suggest
that DA is involved in the age-related decline in male re-
productive function, as indicated by the low FSH, LH
and testosterone levels reported in our previous study
[5].
In rats, the concentrations of DA in the adenohypophysis
increases progressively with age. The increase in the DA
content is not a consequence of reduced metabolism of
DA, nor is it a static pool because as in young rats, ade-
nohypophysial DA is rapidly decreased by pharmacolog-
ical treatments that reduce the activity of
tuberoinfundibular DA neurons. In aged rats, the
amount of DA associated with light particles was 5 times
that found in young rats, whereas the amount of DA as-
sociated with heavy particles was the same as that in
young rats [32]. Therefore, an increased concentration of
DA in anterior hypophysis, like that reported in the
present study in old rats, does not necessarily result in
inhibition of prolactin secretion. It is interesting that, in
addition to DA, impairments are observed in the
processing (binding, accumulation and intracellular dis-
tribution) of hypothalamic hormones in the adenohypo-
physis of old rats. Taken together, these observations are
supportive of the view that the neuroendocrine/endo-
crine changes appearing with age result from a complex
balance of functional alterations occurring at each level,
central and peripheral, of the axis.
In the present study, striatal DA and DOPAC levels and
turnover rate decreased significantly in aged rats. The re-
Figure 3
Twenty-four h changes of NE content and DA turnover in corpus striatum of young and old rats injected with Freund's adju-
vant or its vehicle 18 days earlier. Groups of 5–7 rats were killed by decapitation at six different time intervals throughout a
24-h cycle. Shown are the means + SEM. The groups in which significant differences among time intervals were detected by a
one-way ANOVA are indicated by their F values in the Figure (n.s.: not significant F). For further statistical analysis, see text.BMC Physiology 2001, 1:14 http://www.biomedcentral.com/1472-6793/1/14
sults agree with the bulk of information obtained in aged
rodents indicating decreased levels and turnover rate of
DA [8,9,16,28,33–36]. Generally, the decreased levels of
midbrain DA and DOPAC detectable in aged rats have
little correlation with age-related changes in the density
of dopaminergic receptor binding or the density of DA
uptake sites [37].
Significant amounts of NE and DA are present in the
neurointermediate lobe of the hypophysis. DA nerve ter-
minals belong to centrally located neurons whereas the
origin of NE fibers is in part peripheral, as shown by the
40–50% decrease of posterior pituitary NE content after
the bilateral removal of the sympathetic superior cervical
ganglia [38,39]. Activation of central noradrenergic in-
put to the magnocellular nuclei augments arginine vaso-
pressin release [40] whereas that of peripheral
noradrenergic input decreased arginine vasopressin re-
lease [39]. Data presented herein indicate that reduced
concentrations of DA occurred in the neurointermediate
lobe of the pituitary gland of old rats as compared to
those of young rats. Our present results also indicate that
NE levels in neurointermediate lobe showed significant
24-h variations in all groups except for old rats receiving
Freund's adjuvant. Acrophases were at about the middle
of the activity span (at 02:47 – 04:23 h), in concordance
with the previously reported maxima in tyrosine hydrox-
ylase activity in the superior cervical, stellate and celiac-
superior mesenteric ganglia of young and old rats [41].
Therefore, the central and peripheral sources of no-
radrenergic innervation of hypophysial neurointermedi-
ate lobe seem to have similar 24-h patterns of activation.
NE content in neurointermediate lobe and tyrosine hy-
droxylase in sympathetic ganglia [41] was lowest in old
rats.
A number of studies have indicated an age-related reduc-
tion in immune function associated with cell mediated
immunity in both experimental animals and humans. In
advancing age alterations were mainly observed in T cell
mediated immunity including decreased proliferative re-
sponsiveness of T cells to mitogens, decreased T cell-de-
pendent humoral immune responses, lowered resistance
to tumor cell challenge, decreased graft-vs.-host reactiv-
ity, delayed skin allograft rejection time, impaired de-
layed hypersensitivity, reduced cytolytic immune
response, altered cytokine production after stimulation,
and decreased natural killer cell activity (for references
see [42]). Most of the studies were performed at single
time points in a 24-h cycle, thus overseeing any effect the
circadian system can have on the responses.
In the present study, the injection of Freund's adjuvant
to young and old rats was employed as an antigenic chal-
lenge. The adjuvant-induced arthritis that follows is con-
sidered to be a model for T-lymphocyte-dependent,
autoimmune diseases [43] and the central symptoms
found partly constitute the "sickness behavior", i.e., the
behavioral changes that accompany the immune reac-
tion [44]. One feature of sickness behavior addressed ex-
perimentally in the present study was the modification of
the 24-hour pattern of hypothalamic, striatal and hypo-
physial catecholamines occurring 18 days after the injec-
tion of complete Freund's adjuvant to young and old rats.
Changes in circadian rhythms are apparent at an early
phase of experimental arthritis in rats and persist there-
Table 2: Cosinor analysis on 24-h changes in striatal NE content and DA turnover in young and old rats injected with Freund's adjuvant 
or its vehicle 18 days earlier.
Mesor Amplitude Acrophase (h, min) Percent of rhythm
NE content
Young, Freund's adjuvant 40.1 ± 5.2 21.1 ± 3.6 17:15 ± 01:34 39 ± 4.5
Young, adjuvant's vehicle 49.6 ± 6.6 16.8 ± 2.1 06:29 ± 01:02# 33 ± 5.6
Old, Freund's adjuvant 27.9 ± 4.1* 8.5 ± 2.8** 12:16 ± 02:01 27 ± 5.0
Old, adjuvant's vehicle 30.3 ± 5.4* 12.5 ± 2.2 11:49 ± 02:21 50 ± 7.6
DA turnover
Young, Freund's adjuvant 0.11± 0.03 n.s. n.s. n.s.
Young, adjuvant's vehicle 0.19 ± 0.03* n.s. n.s. n.s.
Old, Freund's adjuvant 0.04 ± 0.03 n.s. n.s. n.s.
Old, adjuvant's vehicle 0.15 ± 0.05# n.s. n.s. n.s.
Shown are the means ± S.E.M. (n = 5–7/group). Mesor and amplitude values are expressed as pg/mg (NE content) or as DOPAC/DA ratio. Percent 
of rhythm defines the part of variation that could be explained by a cosine function in Cosinor. Asterisks designate significant differences (*p < 0.05; 
**p < 0.01) as compared to their respective young counterparts; #p < 0.05 as compared to their respective Freund's adjuvant-treated counterparts 
(one-tailed Student's t test), n.s.: not significant daily changes in a one-way ANOVA.BMC Physiology 2001, 1:14 http://www.biomedcentral.com/1472-6793/1/14
after [45–49]. In the present study Freund's adjuvant ad-
ministration brought about, 18 days later, a decrease of
DA turnover in the anterior hypothalamus and striatum.
It also caused a number of circadian alterations, includ-
ing acrophase delay of DA turnover in medial hypothala-
mus of old rats, acrophase delay of striatal NE content of
young rats and abolished 24-h variations of neurointer-
mediate lobe NE and DA content, and anterior lobe DA
content, in old rats. Experimental evidence suggests that
symptomatology after Freund's adjuvant administration
are a part of a defense response to antigenic challenge
and are mediated by the neural effects of cytokines like
interleukin (IL)-l, IL-6, IL-2, granulocyte-macrophage
colony-stimulating factor and interferon-α  [44,50].
Since we previously reported that immunosuppression
restored rhythmicity of several of the neuroendocrine
parameters examined in Freund's adjuvant-injected rats
[51], the immune-related nature of the studied phenom-
ena seems to be warranted. Suprachiasmatic nuclei
themselves may be sensitive to immune-derived signals.
Presumably, the chronic stress condition given by myco-
bacterial adjuvant injection is instrumental in inhibiting
a number of circadian rhythms at early and late phases of
disease.
Conclusions
Aged rats had lower NE content in the anterior and me-
dial hypothalamus, smaller amplitude of 24-h rhythm in
posterior hypothalamic NE content, lower DA turnover
in medial and posterior hypothalamus, augmented ade-
nohypophysial DA and decreased NE and DA content in
pituitary neurointermediate lobe. These results are prob-
Figure 4
Twenty-four h changes of NE and DA content in hypophysial neurointermediate lobe and of DA content of hypophysial ante-
rior lobe in young and old rats injected with Freund's adjuvant or its vehicle 18 days earlier. Groups of 5–7 rats were killed by
decapitation at six different time intervals throughout a 24-h cycle. Shown are the means + SEM. The groups in which signifi-
cant differences among time intervals were detected by a one-way ANOVA are indicated by their F values in the Figure (n.s.:
not significant F). For further statistical analysis, see text.BMC Physiology 2001, 1:14 http://www.biomedcentral.com/1472-6793/1/14
ably instrumental for the neuroendocrine/endocrine
changes appearing with age. Aged rats had also signifi-
cantly decreased striatal DA and DOPAC levels and turn-
over rate when measured at 6 different time points along
a 24-h cycle, thus agreeing with the bulk of information
obtained at single time points on the occurrence of age-
related decreased levels and turnover rate of DA in cor-
pus striatum.
With advancing age alterations were mainly reported on
T cell mediated immunity. We hereby reported that dur-
ing Freund's adjuvant-induced arthritis (a T-lym-
phocyte-dependent autoimmune disease) a decrease of
DA turnover occurred in the anterior hypothalamus and
striatum. We also observed that responses to immuniza-
tion like suppression of 24-h rhythms of neurointerme-
diate lobe NE and DA and of anterior lobe DA were only
seen in aged rats. Collectively, our results indicate that
24-h rhythms and levels of hypothalamic, striatal and
hypophysial catecholamines are age-dependent, as are
some of the responses to Freund's adjuvant administra-
tion.
Materials and Methods
Animals
Experiments were carried out in adult male Wistar rats,
kept under light between 0800 and 2000 h daily. Light
intensity at the level of the animal cages was about 200
lux. Rats had access to food and water ad libitum. Ade-
quate measures were taken to minimize pain or discom-
fort, in accordance with the principles and procedures
outlined in European Communities Council Directives
(86/609/EEC).
Groups of young (2 months) and aged (18–20 months)
rats were injected s.c. with Freund's complete adjuvant
(0.5 mg heat-killed Mycobacterium butyricum/rat) or its
vehicle (0.5 ml paraffin oil containing 15% mannide mo-
nooleate) 3 h after light on (HALO) (i.e., at 11:00 h). The
effect of varying the time of Freund's adjuvant injection
on day-night differences of submaxillary lymph node or-
nithine decarboxylase activity (an index of lymph node
proliferative response) was examined in a previous work
[52]. Immunization performed during daylight (5 HA-
LO) or at night (18 HALO) resulted in similar day-night
differences in ornithine decarboxylase activity, indicat-
ing that changes in lymph node proliferative responses
were relatively independent of the biological time of my-
cobacterial antigen exposure [52]. We maintained a sim-
ilar injection schedule as in several previous studies
conducted on Freund's adjuvant effects on immune and
endocrine responses [53,54]; thus, rats included in the
present study were injected with Freund's adjuvant at 3
HALO (11:00 h).
Table 3: Cosinor analysis on 24-h changes in hypophysial NE and DA content, in young and old rats injected with Freund's adjuvant or 
its vehicle 18 days earlier.
Mesor Amplitude Acrophase (h, min) Percent of rhythm
NE CONTENT
Neurointermediate lobe
Young, Freund's adjuvant 208 ± 32 117 03:34 ± 01:09 40 ± 7.1
Young, adjuvant's vehicle 216 ± 26 102 ± 14 02:31 ± 02:02 51 ± 6.5
Old, Freund's adjuvant 125 ± 15* n.s. n.s. n.s.
Old, adjuvant's vehicle 149 ± 19* 69 ± 8* 02:34 ± 00:56 37 ± 4.4
DA CONTENT
Neurointermediate lobe
Young, Freund's adjuvant 277 ± 43 125 ± 23 04:23 ± 02:00 30 ± 6.2
Young, adjuvant's vehicle 250 ± 40 171± 48 02:47 ± 01:54 86 ± 12
Old, Freund's adjuvant 174 ± 20* n.s. n.s. n.s.
Old, adjuvant's vehicle 112 ± 42* 49 ± 22* 03:25 ± 01:54 61 ± 11
Anterior hypophysis
Young, Freund's adjuvant 20 ± 3- - -
Young, adjuvant's vehicle 21± 41 1 ± 3 10:31 ± 01:05 75 ± 11
Old, Freund's adjuvant 30 ± 6* n.s. n.s. n.s.
Old, adjuvant's vehicle 39 ± 7* -- -
Shown are the means ± S.E.M. (n = 5–7/group). Mesor and amplitude values are expressed as pg/mg. Percent of rhythm defines the part of variation 
that could be explained by a cosine function in Cosinor. Asterisks designate significant differences (p < 0.05) as compared to the respective young 
counterparts in a one-tailed Student's t test. n.s.: not significant daily changes in a one-way ANOVA; (-): not significant changes in CosinorBMC Physiology 2001, 1:14 http://www.biomedcentral.com/1472-6793/1/14
Although arthritis is induced most easily in inbred Lewis
rats, it is also produced, to a milder extent, in Wistar rats
[55–58]. Rats injected with Freund's adjuvant vehicle
were included as a control of any inflammatory reaction
the adjuvant's oil alone might cause [59–61]. The course
of adjuvant-induced arthritis was followed by behavioral
observations including those of spontaneous behavior-
mobility, exploring, rearing and scratching [4,43]. Eight-
een days after Freund's adjuvant injection a lack of mo-
bility and exploring behavior, an increase in scratching
behavior and signs of hyperalgesia were clearly estab-
lished in young and old rats as compared with their re-
spective adjuvant's vehicle-injected groups. As reported
previously by using plethysmography [62], old rats ex-
hibited less behavioral signs of inflammation (spontane-
ous behavior-mobility, exploring, scratching) than
young rats.
On day 18 after injection, groups of 5–7 rats were killed
by decapitation at 6 different time intervals throughout a
24-hour cycle. The brains were quickly removed and the
hypothalamus, corpus striatum and pituitaries were tak-
en out. The hypothalamus was further sectioned in the
frontal plane, the anterior and posterior regions com-
prising one-third of the block each [63].
Catecholamine assays
Tissue was weighed and homogenized in chilled (0–1°C)
2 M acetic acid. After centrifugation (at 15 000 ×  g for 30
min, at 5°C), the samples were analyzed by high perform-
ance liquid chromatography using electrochemical de-
tection (Coulochem, 5100A, ESA; USA). AC-18 reverse
phase column eluted with a mobile phase (pH 4, 0.1 M
sodium acetate, 0.1 M citric acid, 0.7 mM sodium octyl-
sulphate and 0.57 mM EDTA containing 10% methanol,
v/v), was employed. Flow rate was 1 ml/min, at a pres-
sure of 2200 psi. Fixed potentials against H2/H+ refer-
ence electrode were: conditioning electrode: -0.4 V;
preoxidation electrode: +0.10 V; working electrode:
+0.35 V. Catecholamine concentrations were calculated
from the chromatographic peak heights by using exter-
nal standards. The linearity of the detector response for
NE, DA and DOPAC (a major catabolite of DA) was test-
ed within the concentration ranges found in hypotha-
lamic supernatants. The turnover of DA was assessed by
the DOPAC/DA ratio [64]. Although DOPAC concentra-
tion depends on the balance between catabolite synthesis
and clearance, its acidic nature slows substantially its
clearance from tissue, so that DOPAC concentration re-
flects an integral of past DA release.
Statistical analysis
Statistical analysis of results was performed by a one-
way ANOVA, a two-way factorial ANOVA or one-tailed
Student's t test, as stated. Cosinor analysis was used to
analyze general rhythmic parameters, i.e., acrophase
(the maximum of the cosine function fit to the experi-
mental data), mesor (the statistical estimate of the 24-h
time series mean) and amplitude (half the difference be-
tween maximal and minimal values of the derived cosine
curve). Percent of rhythm defined the part of variation
that could be explained by a cosine function. Statistical
analysis of Cosinor parameters was carried out by stand-
ard procedures [65]. Statistical significance of the de-
rived cosine curves was tested against the null
hypothesis (i.e., amplitude = 0) [66]; p values lower than
0.05 were considered evidence for statistical signifi-
cance.
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